Bausch + Lomb Corporation issued a recall for multiple models of eye implants in its enVista platform after "an increased number of reports of toxic anterior segment syndrome (TASS)," per the recall.

The recall was issued in response to reports of toxic anterior segment syndrome, or TASS, an acute sterile anterior chamber inflammatory reaction that usually develops 12 to 48 hours after surgery.

The company said it was recalling several of its enVista lenses because it received reports of toxic anterior segment syndrome or TASS. The recall affects the company’s enVista Aspire and ...

The recall is associated with its enVista platform following a number of reports of toxic anterior segment syndrome cases by patients who had implanted enVista Envy IOLs, enVista Aspire and some ...

The recall was due to the reports of toxic anterior segment syndrome (TASS, a potential complication in any cataract surgery). The recall may raise short-term concerns regarding product safety and ...

Bausch + Lomb has received reports of toxic anterior segment syndrome in patients with enVista IOLs. No cases have required IOL removal. Perspective from Jennifer Loh, MD Bausch + Lomb has ...

The recall was due to the reports of toxic anterior segment syndrome (TASS, a potential complication in any cataract surgery). The recall may raise short-term concerns regarding product safety and ...